Current Drug Metabolism

A highly motivated, hard-working Biomedical Science researcher; has developed hypotheses and designs for PhD dissertation projects and for current postdoctoral research projects; received a 2018 Postdoctoral Fellowship Award for two years from the American Heart Association (Top 0.14% percentile Rank; 1.3 Impact Score); received 2018 Dean’s Award at the Baylor College of Medicine; received Graduate Research Excellence Fellowship in recognition of outstanding graduate work; years of experience as a PhD student and Postdoctoral researcher in both cancer- and cardiovascular-related research with strong critical thinking, hypothesis driven research design, solid data organization and data analysis skills; a quick learner; a team player with strong communication and interpersonal abilities; always enthusiastic to assimilate new aspects of biomedical research.

Dr. Bing Niu is an Associate Professor in the School of Life Science at Shanghai University, Shanghai, China. His research has focused upon the novel algorithms for bioinformatics techniques and drug design, and has led to authorship on over 50 scientific articles which have been cited more than 500. Currently, he is an editorial board member of Current Bioinformatics. He also served as a guest editor of Biomed Research International, current topics in medicinal chemistry and Current Pharmaceutical Design.

Dr. J.G. Oberlander is currently working as a Project Manager Consultant I in SYNER-G PHARMA CONSUTLING), Southborough, MA, USA. He received his Ph.D. degree in the field of Neurobiology from Boston University, Boston, MA, USA. His research interests are Pharmaceutical and Life Sciences Project Manager with technical expertise in neuronal cell biology and synaptic physiology, and preclinical models of CNS and endocrinology diseases, and CMO management. Extensive research background includes evaluation of medical devices and pharmacologic evaluation of small-molecule and biologics treatments. Strengths include scientific project management, preclinical study design, analytical method development, statistical data analysis, and scientific writing. Leverages creativity, innovative thought processes, and robust problem-solving skills to resolve technical challenges.

Dr. Chandramani Pathak is an Associate Professor in the School of Biological Sciences & Biotechnology, Institute of Advanced Research, (Formerly IIAR), Koba Institutional Area, Puri Foundation, Koba, Gujarat, India. He obtained his PhD in Biochemistry from the School of Studies in Biochemistry, Jiwaji University, Gwalior in 2008. His research interests are Programmed Cell death and inflammation signaling in cancer, Drug delivery, Molecular mechanism of pain and inflammation and molecular basis of diseases i.e. cancer,osteoporosis.